ࡱ> NPO (bjbj 8<; _CCCCCWWW8<W.$.!rCtttCCtXCCt#$Wk0B"TB"#B"C#Hr,4l*vttttB" : 88 Intellectual Property Disclosure A. Identifying Information A. Names of Inventor(s): [Those who contributed intellectually to the invention & made a significant contribution. Please provide the names of other inventors on an attached page.] Name: Home Address: Department: Home Phone #: Campus Address: SS#: Office Phone #: FAX #: Email: _____________________________________________________________________________ Name: Home Address: Department: Home Phone #: Campus Address: SS#: Office Phone #: FAX #: Email: _____________________________________________________________________________ 2. Title of Invention: [Inventions include new processes, products, apparatus, compositions of matter, living organisms - or improvements to existing technology in those categories. Keep in mind that a "catchy" title sometimes helps to get initial attention from potential licensees, and try to keep a broad focus for its potential applications.] __________________________________________________________________________________ Part B. Signature(s) By signing, I (We) understand that in accordance with the 88 Intellectual Property Policy, all inventions which I (we) conceive or develop while employed shall be examined by the University to determine rights and equities therein. I (We) hereby agree to promptly furnish the University with any additional information necessary to this determination. In the event that the University decides to exercise its rights to the invention disclosed herein, I (we) agree to assign all right, title and interest to this invention to 88 under the terms of the Intellectual Property Agreement between the Inventor(s) and the 88 Foundation and to fully cooperate with the University or its designee in securing appropriate protection for the intellectual property embodied in this invention. " Signature of Inventor(s) ___________________________ Date: _________ ______________________ Date: _________ (person completing this disclosure) ___________________________ Date: _________ ______________________ Date: _________ ______________________________________________ Return this form to: Donald F. Hoyt, Associate Vice President for Research, 3801 W. Temple Ave, Pomona, CA 91768-4032; Phone #: 909-869-5461. FAX #: 909-869-2993. Send email messages or requests for an electronic version of this form to: dfhoyt@csupomona.edu Part C. Invention Information (Please attach a separate narrative that responds to each of these items) 1. Description of the Invention. [How would you describe your invention to intelligent people not in your field?] 2. Evidence for Patent. [The criteria for a U.S. Patent are novelty, utility, and non-obviousness.] Please describe in "bulleted" format, evidence you have for each criterion or evidence others might cite against any of the criteria. 1. Novelty: An invention is novel if nothing identical previously existed. How does your invention differ from what already exists? In what ways might it not be unique? 2. Utility: Who might find your invention useful, and why? What companies might be interested in making or selling it, and why? Is there other technology that currently provides similar utility? If so, what is the unique advantage of your invention? 3. Non-obviousness: Non-obviousness measures the degree to which an invention could not have been anticipated from the totally of previous knowledge. At the time it was conceived, why might your invention not have been obvious to people reasonably skilled in the field? Are there ways in which it might be part of an evolutionary trend? 3. Stage of Development. The more resources that companies must invest in a technology to bring it to market, the less initial value they place on the technology. To what extent has your invention been realized in practice so that at least the general principles are demonstrable? Are you working toward a prototype or demonstration of principle? Has the invention been reduced to practice? 4. Expert Opinions. The University has finite funds with which to protect inventions, and its strategy is to patent those inventions most likely to be licensed to a company and provide future. To make the highest quality decision on individual inventions, 88 often seeks the opinion of experts familiar with the field but unrelated to the inventors, especially experts familiar with the commercial potential. Can you suggest experts who can give a confidential opinion on your invention? Please provide a phone number/address. (Assume we will contact anyone you name.) 5. Publication, Sale, or Public Use. Publishing an "enabling" disclosure and applying for patent protection are not mutually exclusive: They can be done simultaneously under the proper circumstances. U.S. patent laws allow one to apply for a patent no later than one year after a public disclosure, such as a published paper, a widely available abstract, or an offer of public sale. However, the moment a public disclosure or publication is made, rights to foreign patents are lost unless a U.S. filing has been made within the preceding twelve months. Foreign protection is important to many international licensees, so inventors are urged to use discretion, take advantage of Confidential Disclosure Agreements available from this office, and file invention disclosures with the University well in advance of presentations or publications. Has your invention been disclosed in an abstract, paper, talk, news story, thesis, or public conversation? If yes, please indicate the type and date of each public disclosure (please enclose copies, if available). b. Is a publication or other disclosure planned in the next six months? If yes, please indicate the type and date of each planned disclosure (please enclose drafts, abstracts, or preprints). c. Are you aware of publications or patents by others that describe anything similar to your invention, even if in a different field? If yes, please give citations and enclose copies of relevant publications or patents if possible. d. Have you sold or offered for sale any products that embody your invention? Have you allowed others outside the University to use your invention? If so, please describe the circumstances and give dates. e. The 88 Foundation may publish a "non-enabling abstract" each year to publicize new inventions that are available to license. Are there reasons why your non-enabling abstract cannot be included in such a brochure? If yes, please specify. 6. Sponsorship. Sponsoring agencies sometimes require the University to disclose inventions that arise from work they fund. If the research that led to your invention was sponsored, please give details. Please include name(s) of government, industry, university, foundation or other sponsor(s), the 88 Foundation account numbers and effective date(s), if known. If your invention has been disclosed to government or industry sponsors, please provide details including names of organizations and their representatives. 7. Addendum. The United States grants patents to those first to invent. Some inventors document the date of their invention by keeping bound notebooks in ink, each page dated and signed with witnessed signatures. If you have not done this, please go back now and sign and date each page of this disclosure form. Please include any other information you think relevant to your invention, such as reports, preprints, excerpts from grant applications, drawings or diagrams, etc. Tabular information showing quantitative or other objective advantages of your invention over existing technology are especially useful. Part D. Declaration of Institutional Support Please attach a completed Declaration of Institutional Support (Inventions) form and obtain the signatures of your Department Chair and College Dean. This form is available from the 88 Foundation and from the Office of Research and Sponsored Programs in Building 1, room 224.     Confidential Information Confidential Information Page of 3 Page of 3 /0EPQRln"  ] _ s u 7Qf-Wbd=>_`ľѷѷѷ᪣Ѿ hj6CJ hI5CJ h}5CJ hM5CJ hj5CJ hjCJ h-5CJ hjCJ hj5CJ hjCJ hj5CJhj56CJ hjCJhj h;y56 hj56 h!*85680QRmn# $ ? \ w  ; ^ ] ^ _ d81$d81$^`d81$^`Pd81$^P`1$$1$a$_ t u f >op 01$^`01$$1$a$pq b!e!n!!e"g"z"##~$$$$$U%%&&''4'e''''((!(:(;(<(>(?(A(B(D(E(G(_(a(y((((((((((((Ļ hr <jhr Uhr hr 56CJhojhoU hj5 hICJ h-CJhj hHCJ hj5CJ hjCJ hj6CJAs c!f"]]]]7 V0zp@ P !$`'0*-/2p5@8;=@CPF Iz1$^z`3 V0zp@ P !$`'0*-/2p5@8;=@CPF Iw1$^w3 & F V0zp@ P !$`'0*-/2p5@8;=@CPF I1$1$f"g"h"i"j"$$%%&&&''2$ V0zp@ P !$`'0*-/2p5@8;=@CPF I1$a$/ V0zp@ P !$`'0*-/2p5@8;=@CPF I1$ ';(=(>(@(A(C(D(F(G(`(a(a5$ V0zp@ P !$`'0*-/2p5@8;=@CPF Id1$a$2$ V0zp@ P !$`'0*-/2p5@8;=@CPF I1$a$2 V0zp@ P !$`'0*-/2p5@8;=@CPF Id1$ a(z({((((]]/ V0zp@ P !$`'0*-/2p5@8;=@CPF I1$>$ V0zp@ P !$`'0*-/2p5@8;=@CPF Id;&&#$+D1$a$2$ V0zp@ P !$`'0*-/2p5@8;=@CPF I1$a$((((((`^/ V0zp@ P !$`'0*-/2p5@8;=@CPF I1$2 V0zp@ P !$`'0*-/2p5@8;=@CPF Id1$;$ V0zp@ P !$`'0*-/2p5@8;=@CPF I;&&#$+D1$a$6:pr @PBP/ =!"# $% ^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH <`< NormalCJ_HmH sH tH DA D Default Paragraph FontViV  Table Normal :V 44 la (k (No List HH M Balloon TextCJOJQJ^JaJ88 SYS_HYPERTEXTB*>*PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] < &@O^^^a(_ f"'a(((8@0(  B S  ?N3^O3^P3^4Q3^R3^dS3^$T3^U3^V3^#W3^#X3^D#Y3^#Z3^[3^L\3^ ]3^̮^3^v_3^tv`3^ԏa3^b3^$c3^hd3^'e3^ *urn:schemas-microsoft-com:office:smarttags PostalCode8*urn:schemas-microsoft-com:office:smarttagsCity9*urn:schemas-microsoft-com:office:smarttagsplace=*urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceName    ; ; = = > > @ A C D F G gm; ; = = > > @ A C D F G 3333&/0<E<<7Q-   qn  ! : 0Eb b : ; ; = = > > @ A C D F G Dp<^`o(.Dp  -r !*8{8AHIMjo ;y}; = @ Ѕ  h@UnknownG* Times New Roman5Symbol3. * Arial5. *aTahomaA BCambria Math#&&&l:l:#d+ + 2HP ?!*82!xxInvention Disclosure Stu Gordondfhoyt Oh+'0  4 @ L Xdlt|Invention Disclosure Stu Gordon Normal.dotmdfhoyt7Microsoft Office Word@2~@@$@(.$l՜.+,D՜.+,L hp  SDSU Foundation:+  Invention Disclosure TitleD@$8_AdHocReviewCycleID_EmailSubject _AuthorEmail_AuthorEmailDisplayName_ReviewingToolsShownOnceVInvention disclosure formsjcarmo@foundation.sjsu.edu Jerri Carmo  !"#$%&()*+,-./012345678:;<=>?@BCDEFGHKRoot Entry F$MData 1Table'R"WordDocument8<SummaryInformation(9DocumentSummaryInformation8ACompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89qRoot Entry F0r;8SData 1Table'R"WordDocument8<  !"#$%&()*+,-./012345678:;<=>?@RQ eID_EmailSubject _AuthorEmail_AuthorEmailDisplayName_ReviewingToolsShownOnceSummaryInformation(9DocumentSummaryInformation8CompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q՜.+,D՜.+,L hp  SDSU Foundation:+  Invention Disclosure Title_AdHocReviewCycl